Penumbra, Boston Scientific
Digest more
Artificial intelligence promises to accelerate scientific discovery and open new frontiers of inquiry. But new research from ...
Thermo Fisher Scientific is starting 2026's J.P. Morgan Healthcare Conference with a bang, announcing two new deals with an ...
Boston Scientific is purchasing heart-device company Penumbra for roughly $14.5 billion in cash and stock, marking the ...
For decades, television advertising has been a game of creativity and repetition. Jingles and mascots became part of our ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The ...
Twice during his Senate confirmation hearings at the end of last month, Robert F. Kennedy Jr., America’s new health secretary, brought up a peer-reviewed study by a certain “Mawson” that had come out ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results